EDAP Expands Ablatherm-HIFU Into China By Entering Exclusive Distribution Agreement
LYON, France, Aug. 26, 2010 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it will expand into the rapidly growing Chinese healthcare market with its Albatherm HIFU device for the treatment of prostate cancer. Ablatherm HIFU will be distributed throughout China by Shaw Han Biomedical Co. Ltd. This exclusive distribution agreement underscores EDAP's global expansion strategy for HIFU in what is the fastest growing medical device market. With the largest population in the world, China represents a significant market for prostate cancer treatment as cancer detection rates rise, awareness of treatment options increases and the expanding aging population garners greater access to healthcare. It is an opportune time to commence the regulatory and marketing process in China for EDAP's robotized, quality-of-life preserving device.
Marc Oczachowski, Chief Executive Officer of EDAP TMS, commented, "This partnership affords a significant market opportunity for EDAP to tap into the rapidly growing medical device market in China. We undertook extensive due diligence to identify the optimal distribution partner to address the large, dynamic and complex Chinese market. This exclusive agreement will involve a two-stage process. Initially, Shaw Han will be responsible for processing the marketing clearance application with China's State Food and Drug Administration (SFDA) for Ablatherm-HIFU for localized prostate cancer treatment. Following receipt of SFDA clearance, Shaw Han will lead the promotion, marketing, and distribution of the device in China for four years post approval. As part of the agreement, Shaw Han has committed to purchase a minimum number of Ablatherm HIFU units during the period covered by the two-stage process."
EDAP's distribution partnership with Shaw Han will officially be announced at the Asian Congress of Urology (ACU) to be held in Taiwan on August 27-28, 2010. Together with its partner, EDAP will showcase its state-of-the-art HIFU and lithotripsy technologies at the ACU.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV